Literature DB >> 10717167

Three-Dimensional Conformal Radiation Therapy In Bronchogenic Carcinoma.

.   

Abstract

Radiotherapy represents one of the primary modalities in the treatment of patients with carcinoma of the lung. Despite significant medical advancements, the outcome of therapy (local control and survival) in patients with unresectable disease is still very disappointing. Although there are some indications in the literature to suggest that higher doses of radiation may result in improved local control, the proximity of critical normal structures to the primary tumor precludes delivery of curative doses without increased risk of unacceptable complications. Three-dimensional conformal radiation therapy has shown a significant potential for improving radiation treatment planning in several sites, both for tumor coverage and sparing normal tissue. Using this technology, significant improvement in uncomplicated locoregional control of lung cancer may be possible. The following is a review of literature and analysis of the currently available information on this subject.

Entities:  

Year:  1996        PMID: 10717167     DOI: 10.1053/SRAO00600092

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  5 in total

Review 1.  Esophagitis, treatment-related toxicity in non-small cell lung cancer.

Authors:  Voichita Bar-Ad; Nitin Ohri; Maria Werner-Wasik
Journal:  Rev Recent Clin Trials       Date:  2012-02

2.  A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012.

Authors:  Shannon E Fogh; Snehal Deshmukh; Lawrence B Berk; Amylou C Dueck; Kevin Roof; Sherif Yacoub; Thomas Gergel; Kevin Stephans; Andreas Rimner; Albert DeNittis; John Pablo; Justin Rineer; Terence M Williams; Deborah Bruner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-11-23       Impact factor: 7.038

Review 3.  Inoperable localized stage I and stage II non-small-cell lung cancer.

Authors:  Eric L Gressen; Walter J Curran
Journal:  Curr Treat Options Oncol       Date:  2002-02

4.  Conformal radiotherapy for lung cancer: interobservers' variability in the definition of gross tumor volume between radiologists and radiotherapists.

Authors:  Chiang J Tyng; Rubens Chojniak; Paula N V Pinto; Marcelle A Borba; Almir G V Bitencourt; Ricardo C Fogaroli; Douglas G Castro; Paulo E Novaes
Journal:  Radiat Oncol       Date:  2009-08-05       Impact factor: 3.481

5.  Personalized dose selection in radiation therapy using statistical models for toxicity and efficacy with dose and biomarkers as covariates.

Authors:  Matthew J Schipper; Jeremy M G Taylor; Randy TenHaken; Martha M Matuzak; Feng-Ming Kong; Theodore S Lawrence
Journal:  Stat Med       Date:  2014-08-27       Impact factor: 2.373

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.